Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis b
Phenotype |liver disease
Sentences 70
PubMedID- 24533061 [54], [55] in brief, the 2013 who guidelines recommend that haart eligibility be expanded to all hiv infected individuals regardless of symptoms if they have a cd4 cell count of less than 500/mm3, or regardless of cd4 count level if there is tb co-infection, or liver disease due to hepatitis b virus co-infection, or for individuals at very high risk for hiv transmission, such as sero-discordant couples and pregnant hiv infected women, who are encouraged to start haart during pregnancy and continue lifelong therapy thereafter, and for children infected with hiv under the age of 5 years old who are also advised to continue lifelong therapy.
PubMedID- 26112990 Interactions of hepatitis b virus infection with nonalcoholic fatty liver disease: possible mechanisms and clinical impact.
PubMedID- 25759633 Secondary or acquired iron overload state, in the absence of an abnormal gene, suggests disorders such as chronic hemolytic anemias, dysmetabolic hyperferritinemia, chronic liver disease due to alcohol, hepatitis b or c, porphyria cutanea tarda and iatrogenic iron overload conditions.
PubMedID- 22760654 liver disease due to chronic hepatitis b virus (hbv) and hepatitis c virus (hcv) infection is now emerging as an increasing cause of morbidity and mortality in human immunodeficiency virus- (hiv-) infected persons in resource-limited settings (rls).
PubMedID- 21331379 Tlr-mediated signals result in liver disease associated with hepatitis b, hepatitis c, alcoholicnonalcoholic steatohepatitis, and hepatic fibrosis [19].
PubMedID- 25596623 Additionally, risk factors such as heavy alcohol use or co-infection with hepatitis b may lead to progression of liver disease even in the presence of svr.
PubMedID- 26226455 liver disease associated with persistent hepatitis b virus (hbv) infection represents a major health problem with global impact.
PubMedID- 22537436 Noninvasive methods to assess liver disease in patients with hepatitis b or c.
PubMedID- 21415769 Background: hepatitis b leads to chronic liver disease, cirrhosis, and hepatocellular cancer.
PubMedID- PMC3315908 liver disease due to chronic hepatitis b and c is now a leading cause of mortality among hiv-infected patients in the developed world.
PubMedID- 25208465 liver diseases were mostly attributed to hepatitis b virus infection (32%).
PubMedID- 22681852 Although several chronic liver diseases are associated with hcc, hepatitis b virus (hbv) and hepatitis c virus (hcv) statistically are the most commonly implicated risk factors.
PubMedID- 22308138 Of late, liver diseases due to chronic hepatitis b and c infection are becoming a leading cause of death and decrease life expectancy among persons with hiv infections worldwide [1].
PubMedID- 21194431 The underlying etiology of liver disease was attributed to hepatitis b virus (hbv) infection if patients were seropositive for hepatitis b surface antigen (hbsag, ria kits, abbott laboratories, north chicago, il, usa) and attributed to hepatitis c virus (hcv) infection if patients were seropositive for an antibody against hcv by a second-generation enzyme immunoassay (abbott laboratories, il).
PubMedID- 23252849 Specific mutations of basal core promoter are associated with chronic liver disease in hepatitis b virus subgenotype d1 prevalent in turkey.
PubMedID- 25923596 Background: one of the more clinically relevant co-morbidities in hiv-infected patients is the development of progressive liver disease due to hepatitis b virus (hbv) or hepatitis c virus (hcv).
PubMedID- 25266850 Additionally, test and treat is recommended for selected groups of hiv-positive individuals, namely, (a) people with tuberculosis in 58 countries, (b) pregnant women in 42 countries, (c) people with liver disease due to hepatitis b co-infection in 52 countries, (d) serodiscordant couples in 35 countries and (e) children below 5 years in nine countries.
PubMedID- 25216239 liver diseases were mostly attributed to hepatitis b virus infection (34%).
PubMedID- 22012714 The virologic determinants of progressive liver disease associated with hepatitis b virus (hbv) remain unclear.
PubMedID- 22980664 [expression of mcp-1 in the patients of chronic hepatitis b complicated with nonalcoholic fatty liver disease].

Page: 1 2